AndreaBozzo/ceres-open-data-index huggingface dataset:
Canada-Manitoba Home and Community Care and Mental Health and Addictions Services Funding Agreement

Canada and Manitoba agreed to a Common Statement of Principles on Shared Health Priorities (hereinafter referred to as the Common Statement, attached hereto as Annex 1) on August 21, 2017, which articulated their shared vision to improve access to home and community care as well as mental health and addictions services in Canada.

Organization: Health Canada | Santé Canada
Canada-New Brunswick Home and Community Care and Mental Health and Addictions Services Funding Agreement

Canada and New Brunswick agreed to a Common Statement of Principles on Shared Health Priorities (hereinafter referred to as the Common Statement, attached hereto as Annex 1) on August 21, 2017,which articulated their shared vision to improve access to home and community care as well as mental health and addictions services in Canada.

Organization: Health Canada | Santé Canada
Letter of agreement to amend bilateral agreements for home and community care and mental health and addiction services (British Columbia)

Further to the Government of Canada's commitment on November 30, 2020, to further support provinces and territories through a new Safe Long-term Care Fund, providing jurisdictions an additional $1 billion, Canada and British Columbia agree, through this Letter of Agreement, to amend the Canada British Columbia Home and Community Care and Mental Health and Addiction Services Agreement  (Bilateral Agreement).

Organization: Health Canada | Santé Canada
Canada-Nova Scotia Home and Community Care and Mental Health and Addictions Services Funding Agreement

Canada and Nova Scotia agreed to a Common Statement of Principles on Shared Health Priorities (hereinafter referred to as the Common Statement, attached hereto as Annex 1) on August 21, 2017, which articulated their shared vision to improve access to home and community care as well as mental health and addictions services in Canada

Organization: Health Canada | Santé Canada
Guidance for reporting on medical assistance in dying

As of November 1, 2018, the Regulations for the Monitoring of Medical Assistance in Dying (the Regulations) require physicians, nurse practitioners, and pharmacists to provide information related to requests for, and the provision of, medical assistance in dying (MAID). This guidance information is intended to support physicians, nurse practitioners, and pharmacists in fulfilling their responsibilities under the Regulations.

Organization: Health Canada | Santé Canada
Canada-Newfoundland and Labrador Home and Community Care and Mental Health and Addictions Services Funding Agreement

Canada and Newfoundland and Labrador agreed to a Common Statement of Principles on Shared Health Priorities (hereinafter referred to as the Common Statement, attached hereto as Annex 1) on August 21, 2017,which articulated their shared vision to improve access to home and community care as well as mental health and addictions services in Canada.

Organization: Health Canada | Santé Canada
Canada-Northwest Territories Home and Community Care and Mental Health and Addictions Services Funding Agreement

Canada and the Northwest Territories agreed to a Common Statement of Principles on Shared Health Priorities (hereinafter referred to as the Common Statement, attached hereto as Annex 1) on August 21, 2017, which articulated their shared vision to improve access to home and community care as well as mental health and addictions services in Canada

Organization: Health Canada | Santé Canada
Letter of agreement to amend bilateral agreements for home and community care and mental health and addiction services (NWT)

Further to the Government of Canada’s commitment on November 30, 2020 to further support provinces and territories through a new Safe Long-term Care Fund (Fund), providing jurisdictions an additional $1 billion, Canada and the NWT agree, through this Letter of Agreement, to amend the Canada-Northwest Territories Home and Community Care and Mental Health and Addiction Services Agreement (Bilateral Agreement).

Organization: Health Canada | Santé Canada
Canada-Nunavut Home and Community Care and Mental Health and Addictions Services Funding Agreement

Canada and Nunavut agreed to a Common Statement of Principles on Shared Health Priorities (hereinafter referred to as the Common Statement, attached hereto as Annex 1) on August 21, 2017, which articulated their shared vision to improve access to home and community care as well as mental health and addictions services in Canada

Organization: Health Canada | Santé Canada
Canada-Ontario Home and Community Care and Mental Health and Addictions Services Funding Agreement

Canada and Ontario agreed to a Common Statement of Principles on Shared Health Priorities (hereinafter referred to as the Common Statement, attached hereto as Annex 1) on August 21, 2017, which articulated their shared vision to improve access to home and community care as well as mental health and addictions services in Canada.

Organization: Health Canada | Santé Canada
Canada-Prince Edward Island Home and Community Care and Mental Health and Addictions Services Funding Agreement

Canada and Prince Edward Island agreed to a Common Statement of Principles on Shared Health Priorities (hereinafter referred to as the Common Statement, attached hereto as Annex 1) on August 21, 2017, which articulated their shared vision to improve access to home and community care as well as mental health and addictions services in Canada

Organization: Health Canada | Santé Canada
Letter of agreement to amend bilateral agreements for home and community care and mental health and addiction services (P.E.I)

Further to the Government of Canada’s commitment on November 30, 2020 to further support provinces and territories through a new Safe Long-term Care Fund, providing jurisdictions an additional $1 billion, Canada and Prince Edward Island agree, through this Letter of Agreement, to amend the Canada- Prince Edward Island Home and Community Care and Mental Health and Addiction Services Agreement (the Bilateral Agreement).

Organization: Health Canada | Santé Canada
Canada-Nunavut Bilateral Agreement for Pan-Canadian Virtual Care Priorities in Response to COVID-19

 Canada and Nunavut agree that immediate action and collaboration was and continues to be needed among governments to expand virtual care services to support improved access to publicly insured health care services for Canadians and to work together to further accelerate the use of virtual care services as a critical channel for delivering care during COVID-19.

Organization: Health Canada | Santé Canada
Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age

The Pfizer-BioNTech and Moderna COVID-19 vaccines are mRNA vaccines that were initially authorized by Health Canada for use in individuals 16 and 18 years of age and older, respectively, in December 2020. On May 5, 2021, Health Canada expanded the Interim Order authorization for the Pfizer-BioNTech COVID-19 vaccine to also include adolescents 12 to 15 years of age based on clinical trial results in this age group.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Vaccination and pregnancy: During pregnancy

Vaccinations during pregnancy protect both you and your developing baby from serious infections. They also help protect infants after birth, when they're too young to be vaccinated. If you're pregnant, you should be vaccinated against whooping cough (pertussis) and flu. Talk to your health care provider or local public health authority about making sure your vaccines are up to date.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
COVID-19: For travellers over 12 without symptoms who are medically exempt from receiving a vaccination

The Government of Canada has put in place emergency measures under the Quarantine Act to slow the introduction and spread of COVID-19 and variants in Canada. Unvaccinated asymptomatic travellers 12 years of age and over are not required to quarantine upon entering Canada if they meet the following conditions: have a medical contraindication for getting a COVID-19 vaccine and comply with the measures outlined below. 

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
COVID-19: Requirements for fully vaccinated travellers and unvaccinated children less than 12 years of age

The Government of Canada has put in place emergency measures under the Quarantine Act to slow the introduction and spread of COVID-19 and variants in Canada. Fully vaccinated travellers without signs and symptoms of COVID-19 are not required to quarantine upon entering Canada if they comply with the requirements in this handout.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Novel Food Information: Insect Resistant and Herbicide Tolerant Corn - MON 87411

Health Canada has notified Monsanto Canada Inc. that it has no objection to the sale of food derived from Insect Resistant and Herbicide Tolerant Corn MON 87411. The Department conducted a comprehensive assessment of this corn event according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
Novel Food Information – 2'-fucosyllactose (2'-FL) from Escherichia coli BL21 (DE3) Strain #1540

Health Canada has notified Jennewein Biotechnologie, GmbH, that it has no objection to the use of 2'-fucosyllactose (2'-FL) derived from a genetically modified strain of E. coli BL21 (DE3), "the production strain" or "the strain", as an ingredient for infant formula. The Department conducted a comprehensive assessment of this oligosaccharide according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
Novel Food Information – Lyophilized Tetraselmis chui strain 8/6 as a novel food

Health Canada has notified Fitoplancton Marino, S.L. (Cádiz, Spain) that it has no objection to the food use of lyophilized Tetraselmis chui. The Department conducted a comprehensive assessment of this microalga according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
Novel Food Information - Herbicide Tolerant Cotton Event GHB811

Health Canada has notified BASF Canada Inc. that it has no objection to the food use of herbicide tolerant cotton event GHB811 (GHB811). This event was initially submitted to the Department as an asset owned by Bayer CropScience Inc. During the assessment of this event, the ownership of this asset was transferred to BASF Canada Inc. The Department conducted a comprehensive assessment of this cotton variety according to its Guidelines for the Safety Assessment of Novel Foods. 

Organization: Health Canada | Santé Canada
Novel Food Information - Herbicide Tolerant Soybean SYHT0H2

Health Canada has notified Syngenta Seeds Canada Inc. and Bayer CropScience Inc. that it has no objection to the sale of food derived from Herbicide Tolerant Soybean SYHT0H2. The Department conducted a comprehensive assessment of this soybean event according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
Novel food information - Herbicide-Tolerant MZHG0JG Corn

Health Canada has notified Syngenta Canada Inc. that it has no objection to the food use of Herbicide-Tolerant MZHG0JG corn . The Department conducted a comprehensive assessment of this corn event according to its Guidelines for the Safety Assessment of Novel Foods. 

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Novel Food Information- Herbicide-Tolerant Rice – HPHI2 Event (Provisia®)

Health Canada has notified BASF that it has no objection to the food use of rice expressing endogenous acetyl-coenzyme A carboxylase (ACCase) containing a single amino acid mutation which confers tolerance to the aryloxyphenoxypropionate (FOP) and cyclohexanediones (DIM) group of herbicides used to control grass weeds. The Department conducted a comprehensive assessment of this rice event according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
Novel Food Information - High Pressure Processing (HPP)-Treated Egg Salad, Egg Dips, and Egg Spreads

Health Canada has notified Burnbrae Farms Ltd., that it has no objection to the food use of High Pressure Processing (HPP)-treated egg salad, egg dips, and egg spreads. The Department conducted a comprehensive assessment of these HPP-treated food products according to its Guidelines for the Safety Assessment of Novel Foods. 

Organization: Health Canada | Santé Canada
Novel Food Information - High Pressure Processing (HPP)-Treated Fruit and Vegetable-Based Juices

Health Canada has notified Gridpath Solutions Inc., that it has no objection to the food use of High Pressure Processing (HPP)-treated fruit and vegetable-based juices. The Department conducted a comprehensive assessment of these HPP-treated food products according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
Novel Food Information - High Pressure Processing (HPP)-Treated Fruit and Vegetable-Based Smoothies

Health Canada has notified Sunflower Organics Inc. (operated as Drinkme Beverage Co.), that it has no objection to the food use of High Pressure Processing (HPP)-treated fruit and vegetable-based smoothies (trade name: Green, Green3, and Ruby). The Department conducted a comprehensive assessment of these HPP-treated food products according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
Novel Food Information - High Pressure Processing (HPP)-Treated Raw Ground Beef (Fressure- fresh ground beef)

Health Canada has notified Gridpath Solutions Inc., on behalf of Cargill Inc., that it has no objection to the food use of High Pressure Processing (HPP)-treated raw ground beef (trade name: Fressure fresh ground beef). The Department conducted a comprehensive assessment of this HPP-treated food product according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
Novel Food Information - Imidazolinone Tolerant (Clearfield') Canola Quality Brassica juncea S006

Health Canada has notified BASF Canada Inc. that it has no objection to the sale of food derived from Imidazolinone Tolerant Canola Quality Brassica juncea S006. The Department conducted a comprehensive assessment of this canola event according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
Novel food information - Meal replacements and formulated liquid diets with added Calcium 3-hydroxy-3-methyl butyrate monohydrate (CaHMB)

Health Canada has notified Abbott Laboratories that it has no objection to the sale of their meal replacements and formulated liquid diets with added calcium 3-hydroxy-3-methyl butyrate monohydrate (CaHMB), manufactured as characterized in the information provided to the Food Directorate. The Food Directorate (FD) has conducted the safety assessments according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
Novel Food Information - Reduced Lignin Alfalfa KK179

Health Canada has notified Monsanto Canada Inc. and Forage Genetics International (hereafter FGI) that it has no objection to the sale of food derived from Reduced Lignin Alfalfa KK179. The Department conducted a comprehensive assessment of this alfalfa event according to its Guidelines for the Safety Assessment of Novel Foods. 

Organization: Health Canada | Santé Canada
Novel Food Information - Simplot Innate® Potato Events Gen2-W8, Gen2-X17, and Gen2-Y9

Health Canada has notified J.R. Simplot Company that it has no objection to the food use of Simplot Innate® potato events Gen2-W8, Gen2-X17, and Gen2-Y9. The Department conducted a comprehensive assessment of these potato events according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
Novel Food Information - Soybean Producing Aryloxyalkanoate dioxygenase-12 (AAD-12) and phosphinothricin acetyltransferase (PAT) - DAS-68416-4

Health Canada has notified Dow Agrosciences Canada, Inc. that it has no objection to the food use of herbicide tolerant soybean event DAS68416-4. The Department conducted a comprehensive assessment of this soybean event according to its Guidelines for the Safety Assessment of Novel Foods. 

Organization: Health Canada | Santé Canada
Novel Food Information - Stearidonic Acid (SDA) Producing Soybean MON 87769

Health Canada has notified Monsanto Canada Inc. that it has no objection to the food use of Stearidonic Acid (SDA) Producing Soybean MON 87769. The Department conducted a comprehensive assessment of these varieties according to its Guidelines for the Safety Assessment of Novel Foods. 

Organization: Health Canada | Santé Canada
Novel Food Information - Sucromalt (Xtend™) as a food ingredient

Health Canada has notified Cargill Inc. that it has no objection to the sale of sucromalt as a food ingredient that can be used as a partial or complete substitute for sweetening agents available in the Canadian market, e.g. sucrose, corn syrup, high fructose corn syrup (HFCS), brown rice syrup and malt syrup. The Department has reviewed the information provided by Cargill Inc. in support of the acceptability and safety of sucromalt as a food ingredient.

Organization: Health Canada | Santé Canada
Novel Food Information - Wheat Bran Extract as a novel food ingredient

Health Canada has notified Fugeia NV that it has no objection to the addition of wheat bran extract (WBE) as a novel food ingredient. The Department has reviewed the information provided by Fugeia NV and conducted the safety assessment which included evaluation of the manufacturing process of WBE, the composition and the nutritional safety of WBE, and the potential for WBE to be toxic or cause an allergic reaction.

Organization: Health Canada | Santé Canada
Novel Food Information: Abiotic Stress and Herbicide Tolerant HB4 Soybean (IND-00410-5)

Health Canada has notified Bioceres Crop Solutions Corp. that it has no objection to the food use of Abiotic Stress and Herbicide Tolerant HB4 Soybean. The Department conducted a comprehensive assessment of this soybean variety according to its Guidelines for the Safety Assessment of Novel Foods.

Organization: Health Canada | Santé Canada
COVID-19: Organized summer activities for children and youth

This is the guidance document for organized summer activities for children and youth. When operating summer activities during the pandemic, extra care and precautions should be considered to help protect children, youth, staff and communities from COVID-19. When case numbers are down and more people are vaccinated against COVID-19, jurisdictions will be adjusting public health measures in their areas. It is important to consider all jurisdictional specific restrictions and work closely with local public health authorities when developing summer programming. 

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Tips and best practices for organizing virtual meetings: Engagement sessions on COVID-19 vaccines and public health measures

When choosing a presenter for your session, consider the specific attributes of your audience and what expertise is available in your community or organization. Identify a mechanism for tracking registrations and participants’ emails. If your event participants speak another language, you might consider hosting a bilingual event. Consider the set-up of the platform that best supports your event and participants.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
SCISAT - data on gases and particles of the ozone

Canada’s SCISAT is studying the complex chemical processes that affect the distribution of ozone in the upper atmosphere, especially over the Artic. From its orbit 650 kilometres above the Earth, its instruments use the light from sunrises and sunsets each day to identify more than 60 gases and particles. This successful mission represents a partnership involving universities, industry, and government.

Organization: Canadian Space Agency | Agence spatiale canadienne
Report on sexually transmitted infections in Canada, 2018

This report provides an update on the epidemiology of three nationally notifiable STIs in Canada: chlamydia, gonorrhea and infectious syphilis (including congenital syphilis) using data up to 2018, by province/territory, age group and sex. In addition, updated information related to syphilis collected through the Public Health Agency of Canada (PHAC) Syphilis Outbreak Investigation Coordination Committee (SOICC) have been included.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
NEOSSAT - Astronomy Data

The dataset includes the astronomical images from the Near-Earth Object Surveillance Satellite (NEOSSat). NEOSSat was launched on February 25, 2013 and it is the first space satellite dedicated to detecting and tracking asteroids and satellites. The suitcase-sized NEOSSat orbits at an altitude of approximately 780 kilometres above the Earth, searching for near-Earth asteroids that are difficult to spot using ground-based telescopes. Because of its lofty location, it is not limited by the day-night cycle and can operate 24/7. It circles the globe every 100 minutes, and, in part due to its large baffle, is able to scan space near the Sun in order to detect asteroids that may someday pass close to Earth. Through NEOSSat, Canada is participating in the international effort of the world’s space agencies to catalogue the near-Earth population of asteroids and produce information that can be used to target new destinations for future space exploration missions.  
More information on NEOSSAT: http://asc-csa.gc.ca/eng/satellites/neossat/default.asp

Organization: Canadian Space Agency | Agence spatiale canadienne
Coronavirus disease (COVID-19): Guidance documents

We have developed a guidance for managing COVID-19. This guidance is for: health professionals who manage clinical care, and infection prevention and control within health care facilities, health professionals who develop public health advice, policies and programs, and a broad range of sectors, including: industry, youth and child care settings, community-based services (for example, services for homeless people), death services and faith community leaders.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Backgrounder: Government of Canada invests millions into mental health and distress centres

This is the backgrounder for the mental health and distress centres. Supporting the mental health and well-being of Canadians, particularly during the COVID-19 pandemic, is a priority for the Government of Canada. A $50 million investment to increase the capacity of distress centres across the country, announced in the 2020 Fall Economic Statement, will help connect Canadians to the appropriate supports and resources. This funding will provide distress centres across Canada with the support they need to meet increased demand for crisis services. 

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
SARS-CoV-2 variants: National definitions, classifications and public health actions

The Public Health Agency of Canada, in collaboration with provincial and territorial public health authorities, established the Canadian SARS-CoV-2 Variant Surveillance Group (CSVSG) to monitor and assess the impact of variants of SARS-CoV-2 on viral transmissibility, disease severity, and efficacy of vaccines, therapeutics, and diagnostics. The CSVSG has developed national definitions, classifications, and public health actions for SARS-CoV-2 Variants of Interest (VOI) and Variants of Concern (VOC).

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada